vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Qnity Electronics, Inc. (Q). Click either name above to swap in a different company.
BioNTech SE is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Qnity Electronics, Inc.). Qnity Electronics, Inc. runs the higher net margin — 12.3% vs -1.9%, a 14.2% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
BNTX vs Q — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.3B |
| Net Profit | $-28.7M | $162.0M |
| Gross Margin | — | 47.0% |
| Operating Margin | -3.1% | — |
| Net Margin | -1.9% | 12.3% |
| Revenue YoY | — | 10.5% |
| Net Profit YoY | — | 48.6% |
| EPS (diluted) | — | $0.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $260.8M | — | ||
| Q3 24 | $1.2B | $1.1B |
| Q1 26 | — | $162.0M | ||
| Q3 25 | $-28.7M | $211.0M | ||
| Q2 25 | $-386.6M | — | ||
| Q3 24 | $198.1M | $199.0M |
| Q1 26 | — | 47.0% | ||
| Q3 25 | — | 45.1% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 47.0% |
| Q1 26 | — | — | ||
| Q3 25 | -3.1% | 21.3% | ||
| Q2 25 | -192.1% | — | ||
| Q3 24 | 0.8% | 21.8% |
| Q1 26 | — | 12.3% | ||
| Q3 25 | -1.9% | 16.5% | ||
| Q2 25 | -148.2% | — | ||
| Q3 24 | 15.9% | 17.3% |
| Q1 26 | — | $0.72 | ||
| Q3 25 | — | $1.01 | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $857.0M |
| Total DebtLower is stronger | — | $4.0B |
| Stockholders' EquityBook value | — | $7.5B |
| Total Assets | — | $14.1B |
| Debt / EquityLower = less leverage | — | 0.54× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $857.0M | ||
| Q3 25 | — | $128.0M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | — | $4.0B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | — | $7.5B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $11.1B |
| Q1 26 | — | $14.1B | ||
| Q3 25 | — | $12.5B | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | — | 0.54× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
